For more than 25 years, Curtis Capeling has focused on assisting clients in the strategic protection and commercialization of their intellectual property assets and rights. He advises start-up and emerging private companies, as well as public companies in a wide variety of industries, including technology, healthcare, consumer products, media and professional services. His practice includes:
Prior to joining Bass, Berry & Sims, Curtis was a shareholder at Harwell Howard Hyne Gabbert & Manner, P.C.
International Technology Law Association
American Intellectual Property Law Association
American Bar Association
Nashville Bar Association
American Health Law Association (AHLA)
Acquistion of a company specializing in rebuilding, repair and service of elevator motors and machines
Representation of Prairie Capital’s portfolio company Family Allergy & Asthma, an allergy medical practice headquartered in Louisville, KY, in its Physician Practice Management transaction with Asthma and Allergy Associates of Florida, an allergy and asthma medical practice in Flordia. Terms of the transaction were not disclosed.
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Nashville Post “101 Top Lawyer” (2011)